Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
Monastiri
K
K
Seket
B
B
Chouchane
S
S
Samama
M M
MM
Mahjoub
T
T
D000022:Abortion, Spontaneous / Q000517:prevention & control*; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use*; D005165:Factor V / Q000187:drug effects* / Q000235:genetics; D005260:Female; D006579:Heterozygote; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome
D000925:Anticoagulants; D017984:Enoxaparin; D010975:Platelet Aggregation Inhibitors; C095381:factor V Leiden; D005165:Factor V; D001241:Aspirin